Perth-based neurology research and developer NeuroDiscovery Ltd has entered into a research collaboration with CSIRO.
Perth-based neurology research and developer NeuroDiscovery Ltd has entered into a research collaboration with CSIRO.
Under the agreement, NeuroDiscovery will screen the CSIRO's Division of Molecular and Health Technologies chemical library to discover new connexin and pannexin drug candidates for the treatment of various neurological conditions, including but not limited to neurological pain.
NeuroDiscovery executive director David McAuliffe said both groups would utilise each other's expertise and capacity in the development of potential new drug candidates.
CSIRO Molecular and Health Technologies chief Graeme Woodrow said CSIRO was ideally positioned as a key provider of scientific capabilities to support the formation and growth of promising Australian companies in the biotechnology sector.
"By forming partnerships with Australian biotech companies, CSIRO can assist companies such as NeuroDiscovery in their growth strategies," said Dr Woodrow.
Subscribe today for award-winning, unbiased and trusted journalism